Abstract
From uncertain beginnings over four decades ago, heart transplantation is now the definitive therapy for end-stage heart failure. This review will attempt to comprehensively cover the broad gamut of anesthetic, hemodynamic, antimicrobial, immunosuppressive and hemostatic agents used by the cardiothoracic anesthesiologist in the perioperative management of patients with endstage heart disease.
Keywords: Heart failure, heart transplantation, volatile anesthetics, opioids, benzodiazepines, immunosuppresants
Current Clinical Pharmacology
Title:Anesthetic Pharmacology and Perioperative Considerations for Heart Transplantation
Volume: 10 Issue: 1
Author(s): Harish Ramakrishna, Kent H. Rehfeldt and Octavio E. Pajaro
Affiliation:
Keywords: Heart failure, heart transplantation, volatile anesthetics, opioids, benzodiazepines, immunosuppresants
Abstract: From uncertain beginnings over four decades ago, heart transplantation is now the definitive therapy for end-stage heart failure. This review will attempt to comprehensively cover the broad gamut of anesthetic, hemodynamic, antimicrobial, immunosuppressive and hemostatic agents used by the cardiothoracic anesthesiologist in the perioperative management of patients with endstage heart disease.
Export Options
About this article
Cite this article as:
Ramakrishna Harish, Rehfeldt H. Kent and Pajaro E. Octavio, Anesthetic Pharmacology and Perioperative Considerations for Heart Transplantation, Current Clinical Pharmacology 2015; 10 (1) . https://dx.doi.org/10.2174/1574884709666140212104958
DOI https://dx.doi.org/10.2174/1574884709666140212104958 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
Hyperglycemia-induced Oxidative Stress and its Role in Diabetes Mellitus Related Cardiovascular Diseases
Current Pharmaceutical Design EDITORIAL: The Modulation of Signal Transduction Pathways as a Promising Therapeutic Approach to Reduce Cardiovascular Diseases
Current Signal Transduction Therapy Extracellular Vesicles and Insulin Resistance: A Potential Interaction in Vascular Dysfunction
Current Vascular Pharmacology Editorial (Thematic Issue: Salt Sensitive Hypertension: Mechanisms, Management, Prognosis and Treatment)
Current Hypertension Reviews Synthesis of 2-(4-substitutedbenzylpiperazin-1-yl)-N-(2-oxo-2,3-dihydrobenzooxazol- 6-yl)acetamides as Inotropic Agents
Medicinal Chemistry Role of Nitric Oxide in the Modulation of Angiogenesis
Current Pharmaceutical Design miRNA-Dependent Activation of mRNA Translation
MicroRNA Type 2 Diabetes and Risk for Functional Decline and Disability in Older Persons
Current Diabetes Reviews Present Drug Therapy of Demyelinating Disorders
Current Drug Therapy Cancer Stem Cells: The Emerging Challenge of Drug Targeting
Current Medicinal Chemistry Regional Differences in Adaptation of CNS Mu Opioid Receptors to Chronic Opioid Agonist Administration
Current Neuropharmacology MiR-147: Functions and Implications in Inflammation and Diseases
MicroRNA Obesity in the Cardiovascular Continuum
Current Clinical Pharmacology Alogliptin; A Review of a New Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for the Treatment of Type 2 Diabetes Mellitus
Cardiovascular & Hematological Disorders-Drug Targets Retinoic Acid Metabolism and Mechanism of Action: A Review
Current Drug Metabolism Structural Basis of Resistance to Anti-Cytochrome bc<sub>1</sub> Complex Inhibitors: Implication for Drug Improvement
Current Pharmaceutical Design PEDF & Stem Cells: Niche vs. Nurture
Current Drug Delivery α-Secretase in Alzheimers Disease and Beyond: Mechanistic, Regulation and Function in the Shedding of Membrane Proteins
Current Alzheimer Research Use of Mouse Models to Evaluate Roles of Nuclear Receptors and their Ligands in the Pathogenesis and Treatment of Atherosclerosis
Current Drug Targets The Synthesis of Nano-Doxorubicin and its Anticancer Effect
Anti-Cancer Agents in Medicinal Chemistry